Literature DB >> 29096355

The long non-coding RNA MALAT1 interacted with miR-218 modulates choriocarcinoma growth by targeting Fbxw8.

Dazun Shi1, Yu Zhang1, Rong Lu1, Yi Zhang2.   

Abstract

Among the first found cancer-related long non-coding RNAs (lncRNAs), MALAT1 is one that involves in the development and progression of some tumors. MALAT1 can be aberrantly expressed in hepatocellular carcinoma, cervical, breast, ovarian cancers, as well as colorectal cancer. The paper aims to make certain the function of MALAT1 in human choriocarcinoma cell lines by investigating the detailed effects and molecular mechanisms. Being specifically upregulated in choriocarcinoma cell lines, the under-researched lncRNA-MALAT1 promoted choriocarcinoma cell growth by targeting miR-218. After MALAT1 knockdown, proliferation of human choriocarcinoma cell in vitro was dramatically hindered, and the tumor size in vivo was reduced. What is more, miR-218-mediated Fbxw8 regulation was required for MALAT1-induced choriocarcinoma cell proliferation. Taken together, MALAT1 might promote choriocarcinoma tumor growth through miR-218-mediated Fbxw8 regulation. According to our data, MALAT1 might be an oncogenic lncRNA that promoted choriocarcinoma proliferation and could be therapeutically targeted in human choriocarcinoma.
Copyright © 2017 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Cell proliferation; Choriocarcinoma; Fbxw8; MALAT1; miR-218

Mesh:

Substances:

Year:  2017        PMID: 29096355     DOI: 10.1016/j.biopha.2017.10.083

Source DB:  PubMed          Journal:  Biomed Pharmacother        ISSN: 0753-3322            Impact factor:   6.529


  15 in total

1.  Long non-coding RNAs in ovarian cancer: expression profile and functional spectrum.

Authors:  Selin Oncul; Paola Amero; Cristian Rodriguez-Aguayo; George A Calin; Anil K Sood; Gabriel Lopez-Berestein
Journal:  RNA Biol       Date:  2019-12-17       Impact factor: 4.652

2.  LncRNA MALAT1/miR-181a-5p affects the proliferation and adhesion of myeloma cells via regulation of Hippo-YAP signaling pathway.

Authors:  Yanbei Sun; Tingxiu Jiang; Yongqing Jia; Jingyun Zou; Xiaoxiao Wang; Weiying Gu
Journal:  Cell Cycle       Date:  2019-08-09       Impact factor: 4.534

3.  Oncogenic KSHV-encoded interferon regulatory factor upregulates HMGB2 and CMPK1 expression to promote cell invasion by disrupting a complex lncRNA-OIP5-AS1/miR-218-5p network.

Authors:  Wan Li; Qingxia Wang; Qi Feng; Fei Wang; Qin Yan; Shou-Jiang Gao; Chun Lu
Journal:  PLoS Pathog       Date:  2019-01-30       Impact factor: 6.823

4.  Down-regulation of DANCR acts as a potential biomarker for papillary thyroid cancer diagnosis.

Authors:  Ke Zhang; Jing Lv; Xiaowei Peng; Jianqiu Liu; Cuilin Li; Jing Li; Ningwei Yin; Hui Li; Zhi Li
Journal:  Biosci Rep       Date:  2019-04-17       Impact factor: 3.840

5.  The long non-coding RNA PCA3: an update of its functions and clinical applications as a biomarker in prostate cancer.

Authors:  Ana Emília Goulart Lemos; Aline da Rocha Matos; Luciana Bueno Ferreira; Etel Rodrigues Pereira Gimba
Journal:  Oncotarget       Date:  2019-11-12

6.  uc.77- Downregulation Promotes Colorectal Cancer Cell Proliferation by Inhibiting FBXW8-Mediated CDK4 Protein Degradation.

Authors:  Zhijian Zheng; Dan Hong; Xiaodong Zhang; Yixin Chang; Ning Sun; Zhenni Lin; Hongyan Li; Shirui Huang; Ruirui Zhang; Qipeng Xie; Haishan Huang; Honglei Jin
Journal:  Front Oncol       Date:  2021-05-19       Impact factor: 6.244

7.  Long noncoding RNA EZR-AS1 promotes tumor growth and metastasis by modulating Wnt/β-catenin pathway in breast cancer.

Authors:  Yu Bai; Xian Zhou; Luo Huang; Yue Wan; Xiaoyu Li; Ying Wang
Journal:  Exp Ther Med       Date:  2018-07-18       Impact factor: 2.447

8.  LncRNA-MALAT1 regulates proliferation and apoptosis of ovarian cancer cells by targeting miR-503-5p.

Authors:  Qian Sun; Qian Li; Fangfang Xie
Journal:  Onco Targets Ther       Date:  2019-08-09       Impact factor: 4.147

9.  The implication of LncRNA MALAT1 in promoting chemo-resistance of laryngeal squamous cell carcinoma cells.

Authors:  Qining Jiang; Shiying Liu; Linna Hou; Yanfei Guan; Shenggang Yang; Zhengyong Luo
Journal:  J Clin Lab Anal       Date:  2019-12-14       Impact factor: 2.352

10.  Knockdown of lncRNA OGFRP1 Inhibits Proliferation and Invasion of JEG-3 Cells Via AKT/mTOR Pathway.

Authors:  Qian Meng; Haiyan Xue
Journal:  Technol Cancer Res Treat       Date:  2020 Jan-Dec
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.